Companies: 10,795·Total market cap: $144.5T

Inhibrx Biosciences, Inc.

Inhibrx Biosciences, Inc.

INXBNASDAQHealthcare

$15.86

+$1.94(+13.94%)

Market Cap$225865416

P/E Ratio—

52W High$18.95

52W Low$12.95

Avg Volume508K

Open$13.85

Beta2.88

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Inhibrx Biosciences, Inc.（INXB）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · INXB · 截至 Jun 9, 2026

关键指标

EPS (TTM)—Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)—Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding—Shares outstanding history

Next EarningsTBAEarnings history

探索 Inhibrx Biosciences, Inc. 数据

分析师预测—

股息不分红

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Inhibrx Biosciences, Inc.

$15.86+13.94%$225.9M #2

Catabasis Pharmaceuticals, Inc.

$8.54-6.97%$234.9M #3

$3.17-7.31%$226.4M #4

Celularity Inc.

$0.81-1.47%$19.5M #5

CARGO Therapeutics, Inc. Common Stock

$4.47+0.00%$216.2M #6

Merrimack Pharmaceuticals, Inc.

$15.15+0.10%$224.0M

股票表现

1D+12.80%

1W+4.89%

1M+13.94%

3M+13.94%

YTD+13.94%

1Y+13.94%

5Y-90.67%

关于 Inhibrx Biosciences, Inc.

CEOMark Paul Lappe

IPO DateApr 24, 2018

Employees166

CountryUS

Websiteinhibrx.com

Inhibrx Biosciences, Inc. operates as a clinical-stage biopharmaceutical entity, primarily focused on developing advanced biologic treatments for critical, life-threatening medical conditions. Key ass…

Biotechnology HealthcareNASDAQADRUS

关于股票概览与关键数据

Inhibrx Biosciences, Inc.（INXB）是 Biotechnology 行业的 Healthcare 类公司，于 Apr 24, 2018 在 NASDAQ 上市。截至最近交易日，INXB 股价为 $15.86，市值约为 $225.9M。过去12个月累计回报 +13.94%，年初至今回报 +13.94%。

常见问题

截至最近一个交易日，Inhibrx Biosciences, Inc.（INXB）股价为 $15.86，在 NASDAQ 上市，52周区间为 $12.95 – $18.95。

INXB 最新股价INXB quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议